Home/Filings/4/A/0001062993-24-010187
4/A//SEC Filing

Sanchez Jill 4/A

Accession 0001062993-24-010187

CIK 0001205922other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 4:35 PM ET

Size

5.9 KB

Accession

0001062993-24-010187

Insider Transaction Report

Form 4/AAmended
Period: 2024-03-21
Sanchez Jill
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-21+805805 total
    Exercise: $8.21Exp: 2034-03-21Common Stock (805 underlying)
Footnotes (2)
  • [F1]Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4.
  • [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date.

Issuer

VACCINEX, INC.

CIK 0001205922

Entity typeother

Related Parties

1
  • filerCIK 0002015024

Filing Metadata

Form type
4/A
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:35 PM ET
Size
5.9 KB